Vikram R. Paralkar

1.1k total citations
24 papers, 619 citations indexed

About

Vikram R. Paralkar is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Vikram R. Paralkar has authored 24 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Hematology and 7 papers in Cancer Research. Recurrent topics in Vikram R. Paralkar's work include Acute Myeloid Leukemia Research (10 papers), RNA modifications and cancer (10 papers) and Cancer-related molecular mechanisms research (7 papers). Vikram R. Paralkar is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), RNA modifications and cancer (10 papers) and Cancer-related molecular mechanisms research (7 papers). Vikram R. Paralkar collaborates with scholars based in United States, United Kingdom and New Zealand. Vikram R. Paralkar's co-authors include Mitchell J. Weiss, Jing Luan, Yu Yao, Ross C. Hardison, Andrew V. Kossenkov, Peng Huang, Gerd A. Blobel, James Davies, Jim R. Hughes and Maxim Pimkin and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Vikram R. Paralkar

24 papers receiving 616 citations

Peers

Countries citing papers authored by Vikram R. Paralkar

Since Specialization

Citations

This map shows the geographic impact of Vikram R. Paralkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikram R. Paralkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikram R. Paralkar more than expected).

Fields of papers citing papers by Vikram R. Paralkar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikram R. Paralkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikram R. Paralkar. The network helps show where Vikram R. Paralkar may publish in the future.

Co-authorship network of co-authors of Vikram R. Paralkar

This figure shows the co-authorship network connecting the top 25 collaborators of Vikram R. Paralkar. A scholar is included among the top collaborators of Vikram R. Paralkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikram R. Paralkar. Vikram R. Paralkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Leukemia mutated proteins PHF6 and PHIP form a chromatin complex that represses acute myeloid leukemia stemness 2025 ·Genes & Development ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kathy Fange Liu, Jennifer J.D. Morrissette, Sandeep Gurbuxani, Vikram R. Paralkar	1
2	Evolving racial/ethnic disparities in AML survival in the novel therapy era 2025 ·Blood Advances ·(unknown), Phyllis A. Gimotty, Andrew Matthews, Ronac Mamtani, Selina M. Luger, Elizabeth O. Hexner, Daria V. Babushok, Shannon R. McCurdy, Noelle V. Frey, (unknown), Saar Gill, Mary Ellen Martin, Vikram R. Paralkar, Ivan Maillard, David L. Porter, Alison W. Loren, Alexander E. Perl, Keith W. Pratz, Kelly Getz, Catherine Lai	1
3	PHF6 suppresses self-renewal of leukemic stem cells in AML 2024 ·Leukemia ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sandeep Gurbuxani, Vikram R. Paralkar	6
4	Construction and validation of customized genomes for human and mouse ribosomal DNA mapping 2023 ·Journal of Biological Chemistry ·(unknown), Maxim Pimkin, Vikram R. Paralkar	13
5	FISH-Flow to quantify nascent and mature ribosomal RNA in mouse and human cells 2023 ·STAR Protocols ·(unknown), (unknown), (unknown), Maxim Pimkin, Vikram R. Paralkar	3
6	Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia 2022 ·Blood Advances ·Andrew Matthews, Alexander E. Perl, Selina M. Luger, Alison W. Loren, Saar Gill, David L. Porter, Daria V. Babushok, Ivan Maillard, Martin Carroll, Noelle V. Frey, Elizabeth O. Hexner, Mary Ellen Martin, Shannon R. McCurdy, Edward A. Stadtmauer, Vikram R. Paralkar, (unknown), Wei‐Ting Hwang, David M. Margolis, Keith W. Pratz	53
7	Transcriptional Plasticity Drives Leukemia Immune Escape 2022 ·Blood Cancer Discovery ·(unknown), (unknown), Jérémie Kalfon, (unknown), Yaser Heshmati, (unknown), (unknown), Joshua M. Dempster, Guillaume Kugener, Vikram R. Paralkar, Charles Y. Lin, Neekesh V. Dharia, Kimberly Stegmaier, Stuart H. Orkin, Maxim Pimkin	12
8	Control of ribosomal RNA synthesis by hematopoietic transcription factors 2022 ·Molecular Cell ·(unknown), (unknown), (unknown), (unknown), Chelsea Thorsheim, (unknown), Yuxi Ai, Long Gao, Kaosheng Lv, Michel G. Tremblay, Tom Moss, Kai Tan, Jeremy E. Wilusz, Austen R. D. Ganley, Maxim Pimkin, Vikram R. Paralkar	11
9	PHF6 Positively Regulates Transcription of Myeloid Differentiation Genes By Binding at Enhancer Regions 2021 ·Blood ·(unknown), (unknown), (unknown), (unknown), (unknown), Maxim Pimkin, Vikram R. Paralkar	1
10	HectD1 controls hematopoietic stem cell regeneration by coordinating ribosome assembly and protein synthesis 2021 ·Cell stem cell ·Kaosheng Lv, (unknown), (unknown), (unknown), Jian‐Gang Ren, (unknown), Ying Cheng, Simone Pellegrino, Alan J. Warren, Vikram R. Paralkar, Wei Tong	42
11	Real World Survival Outcomes of CPX-351 Versus Venetoclax and Azacitadine for Initial Therapy in Adult Acute Myeloid Leukemia 2021 ·Blood ·Andrew Matthews, Alexander E. Perl, Selina M. Luger, Daria V. Babushok, Noelle V. Frey, Saar Gill, Elizabeth O. Hexner, Mary Ellen Martin, Shannon R. McCurdy, David L. Porter, Edward A. Stadtmauer, Alison W. Loren, Vikram R. Paralkar, Ivan Maillard, David M. Margolis, Keith W. Pratz	5
12	PHF6 Restricts AML Acceleration By Promoting Myeloid Differentiation Genes in Leukemic Cells 2020 ·Blood ·(unknown), (unknown), (unknown), (unknown), (unknown), Maxim Pimkin, Vikram R. Paralkar	1
13	Regulation of gene expression by miR-144/451 during mouse erythropoiesis 2019 ·Blood ·Peng Xu, Lance E. Palmer, Christophe Lechauve, Guowei Zhao, Yu Yao, Jing Luan, Anastassios Vourekas, Haiyan Tan, Junmin Peng, John D. Schuetz, Zissimos P. Mourelatos, Gang Wu, Mitchell J. Weiss, Vikram R. Paralkar	36
14	Unlinking an lncRNA from Its Associated cis Element 2016 ·Molecular Cell ·Vikram R. Paralkar, (unknown), Peng Huang, Yu Yao, Andrew V. Kossenkov, (unknown), Jing Luan, James Davies, Jim R. Hughes, Ross C. Hardison, Gerd A. Blobel, Mitchell J. Weiss	184
15	Lineage and species-specific long noncoding RNAs during erythro-megakaryocytic development 2014 ·Blood ·Vikram R. Paralkar, Tejaswini Mishra, Jing Luan, Yu Yao, Andrew V. Kossenkov, Stacie M. Anderson, Margaret C. Dunagin, Maxim Pimkin, (unknown), Diana Sun, Neeraja Konuthula, Arjun Raj, Xiuli An, Narla Mohandas, David M. Bodine, Ross C. Hardison, Mitchell J. Weiss	133
16	Species-Specific Functions For Long Noncoding RNAs During Erythropoeisis 2013 ·Blood ·Vikram R. Paralkar, Tejaswini Mishra, Jing Luan, Yu Yao, Andrew V. Kossenkov, Neeraja Konuthula, Xiuli An, Narla Mohandas, David M. Bodine, Ross C. Hardison, Mitchell J. Weiss	1
17	Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas 2011 ·Bone Marrow Transplantation ·Vikram R. Paralkar, Sunita D. Nasta, (unknown), Jacqueline Smith, (unknown), Mary Ellen Martin, Steven C. Goldstein, Alison W. Loren, Alain H. Rook, (unknown), David L. Porter	21
18	Population Characteristics and Prognostic Factors in Metastatic Non–Small-Cell Lung Cancer: A Fox Chase Cancer Center Retrospective 2008 ·Clinical Lung Cancer ·Vikram R. Paralkar, Tianyu Li, Corey J. Langer	31
19	Worlds Apart — Tuberculosis in India and the United States 2008 ·New England Journal of Medicine ·Vikram R. Paralkar	3
20	Severe Eosinophilia as a Manifestation of Acute Graft-versus-Host Disease 2008 ·Oncology ·Vikram R. Paralkar, Ami Goradia, Selina M. Luger, Alison W. Loren	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact